Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease.
Soedamah-Muthu SS, Colhoun HM, Thomason MJ, Betteridge DJ, Durrington PN, Hitman GA, Fuller JH, Julier K, Mackness MI, Neil HA; CARDS Investigators. Soedamah-Muthu SS, et al. Among authors: neil ha. Atherosclerosis. 2003 Apr;167(2):243-55. doi: 10.1016/s0021-9150(02)00428-8. Atherosclerosis. 2003. PMID: 12818407 Clinical Trial.
Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS).
Raikou M, McGuire A, Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Charlton-Menys V, Fuller JH; CARDS Investigators. Raikou M, et al. Among authors: neil ha. Diabetologia. 2007 Apr;50(4):733-40. doi: 10.1007/s00125-006-0561-4. Epub 2007 Jan 31. Diabetologia. 2007. PMID: 17265034
Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS).
Charlton-Menys V, Betteridge DJ, Colhoun H, Fuller J, France M, Hitman GA, Livingstone SJ, Neil HA, Newman CB, Szarek M, DeMicco DA, Durrington PN. Charlton-Menys V, et al. Among authors: neil ha. Diabetologia. 2009 Feb;52(2):218-25. doi: 10.1007/s00125-008-1176-8. Epub 2008 Oct 30. Diabetologia. 2009. PMID: 18972097 Clinical Trial.
Comparison of the risk of fatal coronary heart disease in treated xanthomatous and non-xanthomatous heterozygous familial hypercholesterolaemia: a prospective registry study.
Neil HA, Huxley RR, Hawkins MM, Durrington PN, Betteridge DJ, Humphries SE; Simon Broome Familial Hyperlipidaemia Register Group and Scientific Steering Committee. Neil HA, et al. Atherosclerosis. 2003 Sep;170(1):73-8. doi: 10.1016/s0021-9150(03)00233-8. Atherosclerosis. 2003. PMID: 12957684
Non-coronary heart disease mortality and risk of fatal cancer in patients with treated heterozygous familial hypercholesterolaemia: a prospective registry study.
Neil HA, Hawkins MM, Durrington PN, Betteridge DJ, Capps NE, Humphries SE; Simon Broome Familial Hyperlipidaemia Register Group and Scientific Steering Committee. Neil HA, et al. Atherosclerosis. 2005 Apr;179(2):293-7. doi: 10.1016/j.atherosclerosis.2004.10.011. Epub 2004 Dec 8. Atherosclerosis. 2005. PMID: 15777544
130 results